Pulmonary embolism epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org] | '''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org] | ||
Revision as of 14:15, 16 September 2011
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism epidemiology and demographics On the Web |
|
Pulmonary embolism epidemiology and demographics in the news |
|
Directions to Hospitals Treating Pulmonary embolism epidemiology and demographics |
|
Risk calculators and risk factors for Pulmonary embolism epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Synonyms and keywords: PE
Overview
There are between 300,000 and 600,000 cases of pulmonary embolism (PE) in the U.S. each year. Without treatment almost 1/3 of patients will die, usually from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only ~ 2 – 8%. Unfortunately, 2/3 of all cases of PE are not diagnosed before the autopsy.